RichardAlanLafayetteMD
Nephrology • Palo Alto, CAProfessor, Medicine - Nephrology, Stanford University Medical Center
Dr. Lafayette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-725-6186Fax+1 650-725-8418
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 1988 - 1991
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1987
New York Medical CollegeClass of 1985
Certifications & Licensure
CA State Medical License 1988 - 2025
MA State Medical License 1992 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Deconvolution of Human Urine across the Transcriptome and Metabolome.Sevahn K Vorperian, Brian C DeFelice, Joseph A Buonomo, Hagop J Chinchinian, Ira J Gray
Clinical Chemistry. 2024-11-04 - Targeting APRIL in the treatment of glomerular diseases.Chee Kay Cheung, Jonathan Barratt, Richard Lafayette, Adrian Liew, Yusuke Suzuki
Kidney International. 2024-11-01 - Stop Sitting on Our RAASes: Get Moving with the Most Effective Care for Our Patients.Richard A Lafayette
Journal of the American Society of Nephrology. 2024-11-01
Journal Articles
- Cause of Kidney Disease and Cardiovascular Events in a National Cohort of US Patients with End-Stage Renal Disease on Dialysis: A Retrospective AnalysisWolfgang C Winkelmayer, Richard A Lafayette, European Heart Journal
Abstracts/Posters
- Facing the Vexing Problem of Recurrent FSGS After Kidney TransplantationRichard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019
- Facing the Vexing Problem of Recurrent FSGS After Kidney TransplantationRichard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019
Press Mentions
An Update on Novel and Investigational IgA Nephropathy TreatmentsNovember 15th, 2024- Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023May 5th, 2023
- Omeros Announces Results from Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy TrialNovember 5th, 2021
- Join now to see all
Grant Support
- Oral Calcimimetic Agent In Secondary HyperparathyroidismNational Center For Research Resources2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
